Q2 FY27 — 3 Nov 2026
Max Healthcare Institute Limited Q2 FY27
Max Healthcare delivered strong operational performance in Q2 FY27, with gross revenue growing 20% YoY to ₹3,219 crore and operating EBITDA rising 18% YoY to ₹820 crore, sustaining a healthy 26.8% EBITDA margin. Growth was underpinned by stable 77% occupancy despite a 14% YoY increase in operational beds, alongside an 8% increase in IP ARPP to ₹2.31 lakhs. Brownfield ramp-ups at Max Smart Saket, Max Mohali, and Max Nanavati progressed well, with Board approval secured for an additional ₹415 crore brownfield expansion across Noida, Vaishali, and BLK-Max.
Read the full call






